---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-26-010269"
form_type: "8-K"
ticker: "CLVT"
cik: "0001764046"
company_name: "CLARIVATE PLC"
filed_at: "2026-07-06T21:00:42+00:00"
generated_at: "2026-07-06T21:02:05.689082+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Clarivate sells Life Sciences & Healthcare business to Altaris for $600M

## Summary
- Purchase price $600M: $500M cash at close, $25M deferred, $75M senior note.
- Transaction expected to close by end of 2026; no shareholder vote required.
- Buyer's termination fee of $33M guaranteed by Altaris funds.
- Henry Levy, President of the business, gets retention agreement: RSU vesting, PSU cancellation, severance if terminated without cause within 6 months post-close.

## SEC filing metadata
- accession: 0000950103-26-010269
- form_type: 8-K
- ticker: CLVT
- cik: 0001764046
- company_name: CLARIVATE PLC
- filed_at: 2026-07-06T21:00:42+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764046/000095010326010269/0000950103-26-010269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764046/000095010326010269/dp249688_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-26-010269
- JSON: https://secwatch.observer/filing/0000950103-26-010269.json
- Plain text: https://secwatch.observer/filing/0000950103-26-010269.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.